Field Clinical Support
Clinical Department | Hybrid
R&D Engineer
R&D Department | Sunnyvale, CA, USA
Prodeon Medical, Inc., Announces Randomization in the Expander-2 Pivotal Clinical Trial
OR Today Prodeon Medical Showcase
OR Today Prodeon Medical Showcase OR Today Editor John Wallace recently interviewed well-known urologists Drs. Bilal Chughtai, Dean Elterman, and Daniel Rukstalis with a focus on PMI and the Urocross™ Expander System, a minimally invasive device under development. The procedure referred to as Prostatic Urethral REshaping (PURE) uses a temporary implant intended to rapidly relieve […]
Data presented at the American Urology Association annual conference
Data presented at the American Urology Association annual conference Prodeon Medical Announces Presentation of Interim Results from its EXPANDER-1 Multicenter Clinical Trial for its Urocross™ Expander System for Symptoms related to Benign Prostatic Hyperplasia Data includes preliminary results from 39 patients at 4 centers across 3 countries – the temporary implant demonstrated the procedure was […]
Interim results of the EXPANDER-1 Clinical Study
Interim results of the EXPANDER-1 Clinical Study TAIPEI, Jan. 27, 2021 — Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign Prostatic Hyperplasia (BPH) treatment solution. XFLO offers a reversible and […]